购物车
- 全部删除
- 您的购物车当前为空
ETX0282 is an orally available, broad spectrum inhibitor of class A and C β-lactamases. Entasis is developing ETX0282 in combination with cefpodoxime proxetil, an orally available cephalosporin approved for treatment of a variety of bacterial infections.
ETX0282 is an orally available, broad spectrum inhibitor of class A and C β-lactamases. Entasis is developing ETX0282 in combination with cefpodoxime proxetil, an orally available cephalosporin approved for treatment of a variety of bacterial infections.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
25 mg | ¥ 23,800 | 10-14周 | |
50 mg | ¥ 31,800 | 10-14周 | |
100 mg | ¥ 41,500 | 10-14周 |
产品描述 | ETX0282 is an orally available, broad spectrum inhibitor of class A and C β-lactamases. Entasis is developing ETX0282 in combination with cefpodoxime proxetil, an orally available cephalosporin approved for treatment of a variety of bacterial infections. |
分子量 | 315.3 |
分子式 | C13H18FN3O5 |
CAS No. | 2209871-83-8 |
存储 | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容